Pruritis: Scratching the surface

European Journal of Cancer Care

Volumn 12, Issue 2, 2003, Pages 162-165

  Bosonnet, Lorraine ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Basic skin care; Malignant cholestasis; Pruritis

Indexed keywords

ANDROGEN; ANTIHISTAMINIC AGENT; BILE ACID; CALAMINE; CHLORPHENIRAMINE; COLESTYRAMINE; CORTICOSTEROID; CROTAMITON; HYDROXYZINE; LORATADINE; NALOXONE; NALTREXONE; ONDANSETRON; OPIATE ANTAGONIST; RIFAMPICIN; SEROTONIN ANTAGONIST; STANOZOLOL;

ARTICLE; BATH; BILE ACID BLOOD LEVEL; BILE DUCT OBSTRUCTION; CANCER PATIENT; CHOLESTASIS; CLOTHING; CORTICOSTEROID THERAPY; CREAM; DIARRHEA; DIETARY INTAKE; DISEASE SEVERITY; DRY SKIN; EXCRETION; HEAT; HUMAN; JAUNDICE; LIVER TOXICITY; MENTAL STRESS; MOISTURE; PANCREAS CANCER; PRURITUS; SEDATION; SIDE EFFECT; SKIN CARE; SKIN TEMPERATURE; SLEEP DEPRIVATION; TOPICAL TREATMENT; BILIARY TRACT TUMOR; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

BILIARY TRACT NEOPLASMS; HUMANS; PRURITUS; SKIN CARE; TREATMENT OUTCOME;

EID: 0141560524     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2003.00395.x     Document Type: Article

References (20)

1. Atherton D. (1995) Eczema in Childhood: the Facts. Oxford University Press, Oxford.
2. Bain V.G. & Minuk G.Y. (1993) Jaundice, ascites, and hepatic encephalopathy. In: Oxford Textbook of Palliative Medicine, (eds. Doyle, D., Hanks, G.W.C., Macdonald, N.) 1st edn. p34. Oxford Medical Publications, London.
3. Baker H. (1989) Clinical Dermatology. p24. Ballière-Tindall, London.
4. Bergasa N.V. & Jones E.A. (1995) The pruritis of cholestasis: potential pathogenetic and therapeutic implications of opioids. Gastroenterology 108, 1582-1588.
5. Bergasa N.V., Talbot T.L. & Alling D.W. (1992) A controlled trial of Naloxone infusions for the pruritis of chronic cholestasis. Gastroenterology 102, 544-549.
6. British Medical Association. (2001) British National Formulary, p. 14. BMJ Books, London.
7. Burr S. (1999) Emollients for managing dry skin conditions. Professional Nurse, 15, 43-48.
8. Cork M.J. (1997) The importance of skin barrier function. Journal of Dermatological Treatment 8, S7-S13.
9. Epstein E. (2001) Common Skin Disorders, 5th edn. p. 94. W.B. Saunders Company, London.
10. Jones E.A. & Bergasa N.V. (1990) Hypothesesis - The pruritis of cholestasis: from bile acids to opiate antagonists. Hepatology 11, 884-888.
11. Kaye P. (1994) A-Z Pocketbook of Symptom Control. p62. EPL Publications, Northampton.
12. Mortimer P.S. (1993) Skin problems in palliative care: Medical aspects. In: Oxford Textbook of Palliative Medicine, (Doyle, D., Hanks, G.W.C., Macdonald, N. eds) 1st edn. p. 390. Oxford Medical Publications, London.
13. Price T.J., Patterson W.K. & Oliver I.N. (1998) Rifampicin as treatment for pruritis in malignant cholestasis. Supportive Care in Cancer 6, 533-535.
14. Raderer M., Muller C. & Scheithauer W. (1994) Ondansetron for pruritis due to cholestasis (letter). New England Journal of Medicine 330, 1540.
15. Raiford D.S. (1995) Pruritis of chronic cholestasis. Quarterly Journal of Medicine, 88, 603-607.
16. Schworer W. & Ramadori G. (1993) Improvement of cholestatic pruritis by Ondansetron (letter). The Lancet, 341, 1277.
17. Twycross R. (1997) Introducing Palliative Care, 2nd edn, pp. 112-114. Radcliffe Medical Press, Oxford.
18. Walsh M. (1997) Wound and skin care. In: Watson's Clinical Nursing and Related Sciences. (ed. Walsh, M.) 5th edn. Chapter 8, Ballière-Tindall, London.
19. Walt R.P., Daneshmend T.K., Fellows I.W. & Toghill P.J. (1998) Effect of Stanozolol on itching in primary biliary cirrhosis (letter). British Medical Journal, 296, 607.
20. Wolfhagen F.H.J., Sternieri E., Hop W.C.J., Vitale G., Bertolotti M. & Van Buuren H.R. (1997) Oral Naltrexone treatment for cholestatic pruritis: a double-blind, placebo-controlled study. Gastroenterology, 113, 1264-1269.